The IGF-I gene has two promoters and six exons and transcribes at least six different mRNAs due to alternative splicing
Therapy with dulaglutide allows many patients to reach and maintain target HbA1c without insulin and sulfonylureas, eliminating the associated hypoglycemia risk
Neurological Deficit Treatment Approaches Severe B12 deficiency can cause serious neurological problems
What to Expect in Your First Week on GLP-1 During the initial days of GLP-1 therapy, most patients notice relatively subtle changes, as the medication requires time to reach therapeutic levels and exert its full effects
(6) Sun H, Warren J, Yip J, et al
About the Experts Yves-Richard Dole, M.D., a general OB/GYN at Mercy Medical Center in Baltimore